CellPly
Immunotherapy
0 open roles Immunotherapy Bologna, Italy 33 employees $16M raised Est. 2013
LIFTT
Rearden
Indaco
Recomec
Schia Ventures
Italian Angels for Growth
About CellPly
- Cellply is a life-science and biotechnology company developing next-generation analytical tools and a diagnostic platform.
- These tools automate cell-based functional assays to deeply characterize cancer immunotherapies and the mode of action of anti-cancer drugs, evaluating immune and tumor cell heterogeneity with single-cell resolution.
CellPly is listed on Rocketlist with 0 active roles. The company is categorized as Immunotherapy in BioTech. CellPly is at Series A stage, with a B2B business model, headquartered in Bologna, Italy. CellPly was founded in 2013 and has 33 employees. CellPly has raised $16M. Active roles are refreshed daily from public hiring sources.